We are committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Our R&D efforts are focused on four therapeutic areas: Oncology, Gastroenterology (GI), Rare Diseases and Neuroscience. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.
The products shown here represent featured products from Takeda’s worldwide portfolio and may not be available in all countries or regions, or may be available under different trademarks, for different indications, in different dosages, or in different strengths. In general, those products are available only by prescription through local healthcare professionals.
Please visit our local country or region website for local information:
Alogliptin benzoate (brand name: Nesina) is a treatment for hyperglycemia (high blood glucose) in Type 2 Diabetes.
Azilsartan is a treatment for hypertension (high blood pressure).
Bortezomib (brand name: Velcade) is a treatment for multiple myeloma (a cancer of the plasma cells) and mantle cell lymphoma (a cancer of the lymph nodes).
Brentuximab vedotin (brand name: Adcetris) is a treatment for post-transplant consolidation, relapsed or refractory Hodgkin lymphoma (cancer of the lymphatic system distinguished by presence of CD30-positive Reed-Sternberg cells) and systemic anaplastic large cell lymphoma (type of aggressive T-cell lymphoma).
Colchicine (brand name: Colcrys) is for the prevention and treatment of gout flares and the treatment of familial Mediterranean fever (FMF).
Dexlansoprazole (brand name: Dexilant) is a treatment for gastric acid-related disorders like gastroesophageal reflux disease (GERD).
Febuxostat (brand name: Uloric) is a treatment for the chronic management of hyperuricemia (excess of uric acid in the blood) in patients with gout.
Ixazomib (brand name: Ninlaro) is a treatment for multiple myeloma (a hematological malignancy).
Lansoprazole is a treatment for gastric acid-related disorders like gastroesophageal reflux disease (GERD).
Leuprorelin acetate is a gonadotropin-releasing hormone agonist (GnRHa) for the treatment for hormone-responsive cancers such as prostate cancer or breast cancer in women. It is also used to treat children with central precocious puberty, women with endometriosis, infertility and to improve anemia in women with uterine leiomyomata (fibroids).
Lubiprostone (brand name: Amitiza) is a treatment for chronic idiopathic constipation (cause of constipation is unknown), opioid-induced constipation: for chronic, non-cancer pain and for women with irritable bowel syndrome with constipation.
Pantoprazole is a treatment for gastric acid-related disorders like gastroesophageal reflux disease (GERD).
Vedolizumab (brand name: Entyvio) is a treatment for moderate to severe ulcerative colitis or moderate to severe Crohn's disease.
Vonoprazan (brand name: Takecab) is a treatment for gastric acid-related disorders like gastroesophageal reflux disease (GERD).
Vortioxetine (brand name: Trintellix) is a treatment for major depressive disorder (MDD).